Bristol-Myers Squibb buy BiotechBee
Start price
07.09.22
/
70%
€69.37
Target price
31.12.25
€100.00
Performance (%)
-12.07%
End price
05.05.23
€61.00
Summary
This prediction ended on 05.05.23 with a price of €61.00. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.07%. Dividends of €1.61 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 2.545% | 2.545% | -6.533% | -19.991% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % | 60,42 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % | 87,82 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % | 66,93 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % | 60,46 % |
According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy mit Kursziel 100,0